Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume 126, Issue 9, Pages 1260-1280
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-04-24
DOI
10.1161/circresaha.120.315937
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of Acute and Recurrent Pericarditis
- (2020) Juan Guido Chiabrando et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interleukin‐1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST‐Segment–Elevation Myocardial Infarction
- (2020) Antonio Abbate et al. Journal of the American Heart Association
- Anti-Inflammatory Therapy with Canakinumab for the Prevention of Hospitalization for Heart Failure
- (2019) Brendan M. Everett et al. CIRCULATION
- Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
- (2019) Yang Yang et al. Cell Death & Disease
- RILONACEPT IN RECURRENT PERICARDITIS: FIRST EFFICACY AND SAFETY DATA FROM AN ONGOING PHASE 2 PILOT CLINICAL TRIAL
- (2019) Allan Klein et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse
- (2019) Stefano Toldo et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
- (2019) Emelia J. Benjamin et al. CIRCULATION
- IL‐1 Receptor Antagonist, Anakinra, Prevents Myocardial Dysfunction in a Mouse Model of Kawasaki Disease Vasculitis and Myocarditis
- (2019) Mark Gorelik et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction
- (2019) Leo F. Buckley et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The NLRP3 inflammasome as pharmacological target
- (2019) Carlo Marchetti JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Inflammasome Formation in Granulomas in Cardiac Sarcoidosis
- (2019) Jordana Kron et al. Circulation-Arrhythmia and Electrophysiology
- Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis
- (2019) Paul M Ridker et al. EUROPEAN HEART JOURNAL
- From Focal Lipid Storage to Systemic Inflammation
- (2019) Peter Libby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The IL-1 family of cytokines and receptors in rheumatic diseases
- (2019) Charles Anthony Dinarello Nature Reviews Rheumatology
- Atherosclerosis
- (2019) Peter Libby et al. Nature Reviews Disease Primers
- Interleukin‐38 alleviates cardiac remodelling after myocardial infarction
- (2019) Yuzhen Wei et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study
- (2019) Massimo Imazio et al. European Journal of Preventive Cardiology
- Determinants of Cardiorespiratory Fitness in Patients with Heart Failure Across a Wide Range of Ejection Fractions
- (2019) Jessie van Wezenbeek et al. AMERICAN JOURNAL OF CARDIOLOGY
- Interleukin-1 Blockade in Cardiovascular Diseases: From Bench to Bedside
- (2018) Leo F Buckley et al. BIODRUGS
- Transgenic Overexpression of IL-37 Protects Against Atherosclerosis and Strengthens Plaque Stability
- (2018) Jing Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Interleukin-1 blockade in cardiovascular diseases: a clinical update
- (2018) Leo F Buckley et al. EUROPEAN HEART JOURNAL
- Prognostic impact of Interleukin-1 receptor antagonist in patients with documented coronary artery disease
- (2018) Niklas Schofer et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Structural Insights of Benzenesulfonamide Analogues as NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization
- (2018) Jacob Fulp et al. JOURNAL OF MEDICINAL CHEMISTRY
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice
- (2018) Delphine Gomez et al. NATURE MEDICINE
- Role of Interleukin-38 in Chronic Inflammatory Diseases: A Comprehensive Review
- (2018) Wang-Dong Xu et al. Frontiers in Immunology
- Primary and Secondary Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction
- (2018) Marco Giuseppe Del Buono et al. AMERICAN JOURNAL OF CARDIOLOGY
- Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury
- (2018) Stefano Toldo et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction
- (2018) Benjamin W. Van Tassell et al. Circulation-Heart Failure
- Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study
- (2018) Benjamin W. Van Tassell et al. CLINICAL CARDIOLOGY
- Development of covalent NLRP3 inflammasome inhibitors: Chemistry and biological activity
- (2018) Massimo Bertinaria et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Innate immunity as a target for acute cardioprotection
- (2018) Coert J Zuurbier et al. CARDIOVASCULAR RESEARCH
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biology of IL-38 and its role in disease
- (2017) Frank L. van de Veerdonk et al. IMMUNOLOGICAL REVIEWS
- Overview of the IL-1 family in innate inflammation and acquired immunity
- (2017) Charles A. Dinarello IMMUNOLOGICAL REVIEWS
- Why CANTOS is a game-changer in Cardiovascular Medicine
- (2017) Antonio Abbate JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Reduction of Myocardial Ischemia–Reperfusion Injury by Inhibiting Interleukin-1 Alpha
- (2017) Adolfo G. Mauro et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- (2017) Paul M Ridker et al. LANCET
- MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
- (2017) Tamas Hickish et al. LANCET ONCOLOGY
- The NLRP3 inflammasome in acute myocardial infarction
- (2017) Stefano Toldo et al. Nature Reviews Cardiology
- Acute Myocardial Infarction
- (2017) Jeffrey L. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-37 suppresses the osteogenic responses of human aortic valve interstitial cells in vitro and alleviates valve lesions in mice
- (2017) Qingchun Zeng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice
- (2017) Qingwei Ji et al. Scientific Reports
- Host and Environmental Factors Influencing Individual Human Cytokine Responses
- (2016) Rob ter Horst et al. CELL
- Interleukin-1 Receptor Activation Potentiates Salt Reabsorption in Angiotensin II-Induced Hypertension via the NKCC2 Co-transporter in the Nephron
- (2016) Jiandong Zhang et al. Cell Metabolism
- From C-Reactive Protein to Interleukin-6 to Interleukin-1
- (2016) Paul M Ridker CIRCULATION RESEARCH
- Anakinra in Fulminant Myocarditis
- (2016) Yoshihiro Noji CRITICAL CARE MEDICINE
- Treating Life-Threatening Myocarditis by Blocking Interleukin-1*
- (2016) Giulio Cavalli et al. CRITICAL CARE MEDICINE
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
- (2016) Bita Shakoory et al. CRITICAL CARE MEDICINE
- Suppression of innate inflammation and immunity by interleukin-37
- (2016) Charles A. Dinarello et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia–reperfusion in the mouse
- (2016) Stefano Toldo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence
- (2016) Antonio Brucato et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interleukin-1 Blockade in Acute Decompensated Heart Failure
- (2016) Benjamin W. Van Tassell et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Cardiac Sarcoidosis
- (2016) David H. Birnie et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy
- (2016) Stephane Heymans et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacological Inhibition of NLRP3 Inflammasome Attenuates Myocardial Ischemia/Reperfusion Injury by Activation of RISK and Mitochondrial Pathways
- (2016) Raffaella Mastrocola et al. Oxidative Medicine and Cellular Longevity
- ST2 Testing for Chronic Heart Failure Therapy Monitoring: The International ST2 Consensus Panel
- (2015) James L. Januzzi et al. AMERICAN JOURNAL OF CARDIOLOGY
- The Biology of ST2: The International ST2 Consensus Panel
- (2015) Domingo A. Pascual-Figal et al. AMERICAN JOURNAL OF CARDIOLOGY
- Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies)
- (2015) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
- (2015) Hendrik B. Sager et al. CIRCULATION
- Anti-Inflammatory Treatment With Colchicine in Acute Myocardial InfarctionClinical Perspective
- (2015) Spyridon Deftereos et al. CIRCULATION
- Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development inLdlr−/−mice
- (2015) Tim Hendrikx et al. FEBS Journal
- Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients
- (2015) Altaf Afrasyab et al. HEART AND VESSELS
- Formation of the inflammasome during cardiac allograft rejection
- (2015) Keyur B. Shah et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Protective Effect of Interleukin-37 on Vascular Calcification and Atherosclerosis in Apolipoprotein E-Deficient Mice with Diabetes
- (2015) Meng Chai et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Rabbit models for the study of human atherosclerosis: From pathophysiological mechanisms to translational medicine
- (2015) Jianglin Fan et al. PHARMACOLOGY & THERAPEUTICS
- Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33
- (2015) Wei-Yu Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Colchicine—Update on mechanisms of action and therapeutic uses
- (2015) Ying Ying Leung et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications
- (2015) Christian Herder et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis
- (2014) Yan Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Interleukin-18 mediates interleukin-1-induced cardiac dysfunction
- (2014) Stefano Toldo et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury
- (2014) Yi Liu et al. BASIC RESEARCH IN CARDIOLOGY
- Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart
- (2014) Stefano Toldo et al. CARDIOVASCULAR RESEARCH
- Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice
- (2014) B. Wu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Pharmacokinetic and Pharmacodynamic Characteristics of Single-dose Canakinumab in Patients With Type 2 Diabetes Mellitus
- (2014) Adele Noe et al. CLINICAL THERAPEUTICS
- The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
- (2014) A. C. Morton et al. EUROPEAN HEART JOURNAL
- Nlrp3 plays no role in acute cardiac infarction due to low cardiac expression
- (2014) Willeke M.C. Jong et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Formation of the inflammasome in acute myocarditis
- (2014) Stefano Toldo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Interleukin-1β Blockade Improves Left Ventricular Systolic/Diastolic Function and Restores Contractility Reserve in Severe Ischemic Cardiomyopathy in the Mouse
- (2014) Stefano Toldo et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Anti-Inflammatory Strategies for Ventricular Remodeling Following ST-Segment Elevation Acute Myocardial Infarction
- (2014) Ignacio M. Seropian et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial
- (2014) Massimo Imazio et al. LANCET
- Elevated Plasma IL-37, IL-18, and IL-18BP Concentrations in Patients with Acute Coronary Syndrome
- (2014) Qingwei Ji et al. MEDIATORS OF INFLAMMATION
- IL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF-κB pathways
- (2014) HONGLEI YIN et al. Molecular Medicine Reports
- The inflammatory response in myocardial injury, repair and remodelling
- (2014) Nikolaos G. Frangogiannis Nature Reviews Cardiology
- IL-37 Inhibits Inflammasome Activation and Disease Severity in Murine Aspergillosis
- (2014) Silvia Moretti et al. PLoS Pathogens
- Anti-Inflammatory Treatment With Colchicine in Stable Chronic Heart Failure
- (2014) Spyridon Deftereos et al. JACC-Heart Failure
- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
- (2013) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)
- (2013) Benjamin Wallace Van Tassell et al. AMERICAN JOURNAL OF CARDIOLOGY
- Genetic and Pharmacologic Disruption of Interleukin-1β Signaling Inhibits Experimental Aortic Aneurysm Formation
- (2013) William F. Johnston et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury
- (2013) Øystein Sandanger et al. CARDIOVASCULAR RESEARCH
- Targeting Interleukin-1 in Heart Disease
- (2013) Benjamin W. Van Tassell et al. CIRCULATION
- NLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis
- (2013) Fei Zheng et al. Heart Lung and Circulation
- Interleukin-1β induces a reversible cardiomyopathy in the mouse
- (2013) Benjamin W. Van Tassell et al. INFLAMMATION RESEARCH
- A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse
- (2013) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- A Randomized Trial of Colchicine for Acute Pericarditis
- (2013) Massimo Imazio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic Cardiomyocytes
- (2013) Elena Vecile et al. PLoS One
- Cholesterol Diet Withdrawal Leads to an Initial Plaque Instability and Subsequent Regression of Accelerated Iliac Artery Atherosclerosis in Rabbits
- (2013) Vivek Khanna et al. PLoS One
- The Interleukin-1α Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines
- (2013) Busun Kim et al. Frontiers in Immunology
- Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice
- (2012) Fumitake Usui et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Caspase-1 Deficiency Decreases Atherosclerosis in Apolipoprotein E-Null Mice
- (2012) Jessica Gage et al. CANADIAN JOURNAL OF CARDIOLOGY
- Recombinant Human Interleukin-1 Receptor Antagonist Provides Cardioprotection During Myocardial Ischemia Reperfusion in the Mouse
- (2012) Stefano Toldo et al. CARDIOVASCULAR DRUGS AND THERAPY
- Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
- (2012) Paul M Ridker et al. CIRCULATION
- Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
- (2012) C. Cavelti-Weder et al. DIABETES CARE
- Interleukin-1β blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse
- (2012) Stefano Toldo et al. EXPERIMENTAL PHYSIOLOGY
- The effect of colchicine on pyrin and pyrin interacting proteins
- (2012) Ekim Z. Taskiran et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
- (2012) Stefan M. Nidorf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
- (2012) Benjamin W. Van Tassell et al. PLoS One
- IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist
- (2012) F. L. van de Veerdonk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice
- (2011) Vinay Bhaskar et al. ATHEROSCLEROSIS
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
- (2011) C. A. Dinarello BLOOD
- Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
- (2011) Masanori Kawaguchi et al. CIRCULATION
- Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice
- (2011) Matthew R. Alexander et al. JOURNAL OF CLINICAL INVESTIGATION
- Alterations in the Interleukin-1/Interleukin-1 Receptor Antagonist Balance Modulate Cardiac Remodeling following Myocardial Infarction in the Mouse
- (2011) Antonio Abbate et al. PLoS One
- The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
- (2011) E. Mezzaroma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome
- (2011) P Menu et al. Cell Death & Disease
- Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
- (2010) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Interleukin-1β modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse
- (2010) Antonio Abbate et al. EUROPEAN JOURNAL OF HEART FAILURE
- Interleukin-1 Trap Attenuates Cardiac Remodeling After Experimental Acute Myocardial Infarction in Mice
- (2010) Benjamin W Van Tassell et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- IL-33 Reduces Macrophage Foam Cell Formation
- (2010) J. E. McLaren et al. JOURNAL OF IMMUNOLOGY
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
- (2010) Kristiina Rajamäki et al. PLoS One
- Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling
- (2009) Kenjiro Seki et al. Circulation-Heart Failure
- In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes
- (2009) Helen J. Lachmann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interleukin-1 Regulates Multiple Atherogenic Mechanisms in Response to Fat Feeding
- (2009) Janet Chamberlain et al. PLoS One
- Differential requirement for the activation of the inflammasome for processing and release of IL-1 in monocytes and macrophages
- (2008) M. G. Netea et al. BLOOD
- Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
- (2008) Ignatios Ikonomidis et al. CIRCULATION
- Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial Infarction
- (2008) Antonio Abbate et al. CIRCULATION
- IL-33 reduces the development of atherosclerosis
- (2008) Ashley M. Miller et al. JOURNAL OF EXPERIMENTAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search